Back

Systematic review and meta-analysis of GLP-1 receptor agonists in heart failure: impact on 6-minute walk test performance

28 August 2026 (11:15 - 12:00)
Organised by: Logo
Congress Presentation Part of: Heart failure: integrating therapies and education Pharmacotherapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Theodoros Christophides

Nicosia General Hospital, Nicosia (Cyprus)

6 More presentations in this session

Presentation thumbnail
Additive benefits of combination ARNI and SGLT2 inhibitor therapy in real-world heart failure: a propensity-weighted analysis of 11,483 asian patients
Doctor P. Amornritvanich (Bangkok, TH)
Abstract Slides Video
Presentation thumbnail
Low blood pressure and the effect of SGLT2 inhibitors in heart failure with reduced ejection fraction: data from the China Cardiovascular Association Database-Heart Failure Center Registry
Doctor W. Jin (Shanghai, CN)
Abstract Slides Video
Presentation thumbnail
Hyperkalemia and its outcome implications in patients with heart failure with reduced ejection fraction: results from a single-center cohort
Doctor M. Mantovani (Modena, IT)
Abstract Slides Video
Presentation thumbnail
Efficacy of sodium–glucose cotransporter 2 inhibitors in heart failure patients with low body mass index
Doctor K. Nakamoto (Osaka, JP)
Abstract Slides Video
Presentation thumbnail
Outcomes of sacubitril/valsartan plus SGLT2 inhibitors versus SGLT2 inhibitors in heart failure with reduced ejection fraction: a propensity-matched real-world analysis
Doctor O. Alameen (Doha, QA)
Abstract Slides Video

Access the full session

Session thumbnail
Heart failure: integrating therapies and education

The Event

Event poster

ESC Congress 2026

28 August 2026 11:15 CET
You may be interested in
thumbnail
Congress Presentation
GLP-1 receptor agonists for obesity-related heart failure with preserved ejection fraction: a systematic review and meta-analysis of randomized controlled trials
30 August 2025
thumbnail
Congress Presentation
Dapagliflozin effect on cardiopulmonary function, reverse cardiac remodelling and biomarkers in a cohort of HFrEF patients
12 May 2024
thumbnail
Congress Presentation
The effect of sex on SGLT-2 antagonists and GLP-1 agonists in the treatment of heart failure: a systematic review and meta-analysis
12 May 2024
thumbnail
Congress Presentation
Circulating concentrations and prognostic value of incretin hormones GLP-1 and GIP-1 in patients with heart failure.
13 May 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources